Carbohydrate Metabolism in Liver Disease

  • P. B. Soeters
  • J. E. G. de Boer
  • R. J. Oostenbroek
  • M. A. Janssen


The purpose of this chapter is not to give a comprehensive overview of all aspects of fat and carbohydrate metabolism but to focus on glucose intolerance, its possible causes and the possible relationship with changes in fat metabolism. Facts with regard to metabolic disorders in liver disease are accumulating rapidly but the mechanisms involved are far from understood.


Liver Disease Cirrhotic Patient Glucose Intolerance Ketone Body Glucagon Secretion 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    C. M. Leevy, C. M. Ryan, and J. C. Fineberg, Diabetes mellitus and liver dysfunction: etiologic and therapeutic considerations, Am. J. Med. 8: 290 (1950).PubMedCrossRefGoogle Scholar
  2. 2.
    P. K. Bondy, Some metabolic anormalities in liver disease, Am. J. Med. 24: 428 (1958).PubMedCrossRefGoogle Scholar
  3. 3.
    R. Hed, Clinical studies in chronic alcoholism. I. Incidence of diabetes mellitus in portal cirrhosis, Acta Med. Scand. 162: 189 (1958).PubMedCrossRefGoogle Scholar
  4. 4.
    J. P. Felber, P. Magnenat, and A. Vannotti, Tolérance au glucose diminuée et réponse insulinique élevée dans la cirrhose, Schweiz. Med. Wschr 97: 1537 (1967).PubMedGoogle Scholar
  5. 5.
    J. R. Collins and O. B. Crofford, Glucose intolerance and insulin resistance in patients with liver disease, Arch. Int. Med. 124: 142 (1969).CrossRefGoogle Scholar
  6. 6.
    J. Marco, J. Diego, M. L. Villanueva, M. Diaz-Fierros, I. Valverde, and J. M. Segovia, Elevated plasma glucagon levels in cirrhosis of the liver, New Engl. J. Med. 89: 1107 (1973).CrossRefGoogle Scholar
  7. 7.
    R. Sherwin, P. Joshi, R. Hendler, Hyperglucagonemia in Laennec’s cirrhosis. The role of portal-systemic shunting, New Engl. J. Med. 290: 239 (1974).PubMedCrossRefGoogle Scholar
  8. 8.
    R. S. Sherwin, M. Fisher, J. Bessoff, N. Snyder, R. Hendler, H. O. Conn,and P. Felig, Hyperglucagonemia in cirrhosis: altered secretion and sensitivity to glucagon, Gastroenterology 74: 1224 (1978).PubMedGoogle Scholar
  9. 9.
    A. Mortiaux and A. M. Dawson, Plasma free fatty acid in liver disease, Gut 2: 304 (1961).PubMedCrossRefGoogle Scholar
  10. 10.
    K. G. M. M. Alberti and D. G. Johnston, Carbohydrate Metabolism in Liver Disease in:“Liver and Biliary Disease, Pathophysiology, Diagnosis, Management” R. Wright, ed., W. B. Saunders Company Ltd., London, Philadelphia, Toronto (1979).Google Scholar
  11. 11.
    H. Ring-Larsen, B. Hesse, J. H. Henriksen,and N. J. Christensen, Sympathetic nervous activity and renal and systemic hemodynamics in cirrhosis: Plasma norepinephrine concentration, hepatic extraction and renal release Hepatology 2: 304 (1982).PubMedCrossRefGoogle Scholar
  12. 12.
    O. Riggio, M. Merli, C. Cangiano, R. Capocaccia, A. Cascino, A. Lala, F. Leonetti, M. Mauceri, M. Pepe, F. Rossi-Fanelli, M. Savioli, G. Tamburrano,and L. Capocaccia, Glucose intolerance in liver cirrhosis, Metabolism 31: 627 (1982).PubMedCrossRefGoogle Scholar
  13. 13.
    R. S. Sherwin, Effect of epinephrine on fuel metabolism in man: Role in the response to stress. Proceedings of the 4th Espen Congress, Vienna. In press (1982).Google Scholar
  14. 14.
    P. R. Black, D. C. Brooks, P. Q. Bessey, R. R. Wolfe, and D. W. Wilmore, Mechanisms of insulin resistance following injury, Ann. Surg. 196: 420 (1982).PubMedCrossRefGoogle Scholar
  15. 15.
    D. C. Deibert and R. A. DeFronzo, Epinephrine-induced insulin resistance in man, J. Clin. Invest. 65: 717 (1980).PubMedCrossRefGoogle Scholar
  16. 16.
    J. E. Liljenquist and D. Rabin, Lack of a role for glucagon in the disposal of an oral glucose load in normal man, J. Clin. Endocrinol. Metab. 49: 937 (1979).PubMedCrossRefGoogle Scholar
  17. 17.
    R. H. Unger and L. Orci, Role of glucagon in diabetes, Arch. Int. Med. 137: 482 (1977).CrossRefGoogle Scholar
  18. 18.
    H. N. Munro, D. Fernstrom,and R. J. Wurtman, Insulin, plasma amino acid imbalance and hepatic coma, Lancet 1: 722 (1975).PubMedCrossRefGoogle Scholar
  19. 19.
    C. O. Record, R. A. Chase, K. G. M. M. Alberti,and R. Williams, Disturbances in glucose metabolism in patients with liver damage due to paracetamol overdose, Clin. Sci. Mol. Med. 49: 473 (1975).PubMedGoogle Scholar
  20. 20.
    K. G. M. M. Alberti, C. O. Record, D. H. Williamson, and R. Wright, Metabolic changes in active chronic hepatitis, Clin. Sci. Mol. Med. 42: 591 (1972).Google Scholar
  21. 21.
    P. B. Soeters, G. Weir, A. M. Ebeid, and J. E. Fischer, Insulin, glucagon, portal systemic shunting and hepatic failure in the dog, J. Surg. Res. 23: 183 (1977).PubMedCrossRefGoogle Scholar
  22. 22.
    P. Rous and L. D. Larimore, Relation of the portal blood to liver maintenance: A demonstration of liver atrophy condition on compensation, J. Exp. Med. 31: 600 (1920).Google Scholar
  23. 23.
    T. E. Starzi, K. Watanabe, and K. A. Porter, Effect of insulin, glucagon and insulin/glucagon infusions on liver morphology and cell division after complete portacaval shunt in dogs, Lancet 1: 821 (1976).CrossRefGoogle Scholar
  24. 24.
    H. O. Conn, Ammonia tolerance as an index of portal-systemic collateral circulation in cirrhosis, Gastroenterology 41: 97 (1961).PubMedGoogle Scholar
  25. 25.
    A. R. Burchell, A. H. Moreno, W. F. Panke, and T. F. Nealon, Hepatic artery flow improvement after portacaval shunt: a single haemodynamic clinical correlate, Ann. Surg. 184: 289 (1976).PubMedCrossRefGoogle Scholar
  26. 26.
    P. J. Lefebvre and A. S. Luyckx, Effect of acute kidney exclusion by ligation of renal arteries on peripheral plasma glucagon levels and pancreatic glucagon production in the anesthetized dog, Metabolism 24: 1169 (1975).PubMedCrossRefGoogle Scholar
  27. 27.
    S. C. Woods and D. Porte, Jr., Neural control of the endocrine pancreas, Physiol. Rev. 54: 596 (1974).PubMedGoogle Scholar
  28. 28.
    L. Orci, A portrait of the pancreatic beta cell, Diabetologia 10: 163 (1974).PubMedCrossRefGoogle Scholar
  29. 29.
    J. P. Palmer, D. P. Henry, J. W. Benson, D. G. Johnson, and J. W. Ensinck, Glucagon response to hypoglycemia in sympatectomized man, J. Clin. Invest. 57: 522 (1976).PubMedCrossRefGoogle Scholar
  30. 30.
    J. Iversen, Adrenergic receptors and the secretion of glucagon and insulin from the isolated perfused canine pancreas., J. Clin. Invest. 52: 2102 (1973).PubMedCrossRefGoogle Scholar
  31. 31.
    J. E. Gerich, J. H. Karam, and P. H. Forsham, Stimulation of glucagon secretion by epinephrine in man, J. Clin. Endocrin. Metab. 37: 479 (1973).CrossRefGoogle Scholar
  32. 32.
    J. E. Gerich, M. Langlois, C. Noacco, V. Schneider, and P. H. Forsham, Adrenergic modulation of pancreatic glucagon secretion in man, J. Clin. Invest. 53: 1441 (1974).PubMedCrossRefGoogle Scholar
  33. 33.
    E. J. Rayfield, D. T. George, H. L. Eichner, and T. H. Tsu, L-Dopa stimulation of glucagon secretion in man, New Engl. J. Med. 293: 589 (1975).PubMedCrossRefGoogle Scholar
  34. 34.
    J. W. Ensinck, R. M. Walter, J. P. Palmer, R. G. Brodows, and R. G. Campbell, Glucagon responses to hypoglycemia in Adrenalectomized Man, Metabolism 25: 227 (1976).PubMedCrossRefGoogle Scholar
  35. 35.
    J. P. Palmer, J. Halter, and P. L. Werner, Differential effect of isoproterenol on acute glucagon and insulin release in man, Metabolism 28: 237 (1979).PubMedCrossRefGoogle Scholar
  36. 36.
    A. S. Luyckx and P. J. Lefebvre, Arguments for a regulation of pancreatic glucagon secretion by circulating plasma free fatty acids, Proc. Soc. Exp. Biol. Med. 133: 524 (1970).PubMedGoogle Scholar
  37. 37.
    S. S. Andrews, S. A. Lopez, and W. G. Blackard, Effect of lipids on glucagon secretion in man, Metabolism 24: 35 (1975).PubMedCrossRefGoogle Scholar
  38. 38.
    J. K. Wise, R. Hendler, and P. Felig, Influence of glucocorticoids on glucagon secretion and plasma amino acid concentrations in man, J. Clin. Invest. 52: 2774 (1973).PubMedCrossRefGoogle Scholar
  39. 39.
    E. Holm, Personal communication.Google Scholar
  40. 40.
    M. R. Lunzer, S. P. Newman, A. G. Bernard, K. K. Manghani, S. P. V. Sherlock, and J. Ginsburg, Impaired cardiovascular responsiveness in liver disease, Lancet 2: 382 (1975).PubMedCrossRefGoogle Scholar
  41. 41.
    D. G. Johnston, K. G. M. M. Alberti, O. K. Faber, and C. Binder, Hyperinsulinism of hepatic cirrhosis: diminished degradation or hypersecretion? Lancet, January 1: 10 (1977).Google Scholar
  42. 42.
    D. G. Johnston, K. G. M. M. Alberti, R. Wright, G. Smith-Laing, A. M. Stewart, S. Sherlock, O. Faber,and C. Binder, C-peptide and insulin in liver disease, Diabetes 27 (Suppl. 1): 201 (1978).PubMedGoogle Scholar
  43. 43.
    G. Smith-Laing, S. Sherlock, and O. K. Faber, Effects of spontaneous portal-systemic shunting on insulin metabolism, Gastroenterology 76: 685 (1979).PubMedGoogle Scholar
  44. 44.
    A. I. Katz and A. H. Rubenstein, Metabolism of pro-insulin, insulin and C-peptide in the rat, J. Clin. Invest. 52: 1113 (1973).PubMedCrossRefGoogle Scholar
  45. 45.
    R. W. Stoll, J. L. Touber, L. A. Menahan, and R. H. Williams, Clearance of porcine, insulin, pro-insulin and connecting peptides by the isolated rat liver, Proc. Soc. Exp. Biol. Med. 133: 894 (1970).PubMedGoogle Scholar
  46. 46.
    C. Kúhl, O. K. Faber, P. Hornnes, and S. Jensen Lindkaer, Cpeptide metabolism and the liver, Diabetes 27 (Suppl. 1): 197 (1978).PubMedGoogle Scholar
  47. 47.
    G. Oehler, H. Bleyl,and K. J. Matthes, Glucose tolerance and serum insulin in different chronic liver diseases. VI International Congress of Liver Diseases, Basel, October 15–17, Abstract no. 145 (1982).Google Scholar
  48. 48.
    P. Vannini, G. Forlani, G. Marchesini, and E. Pisi, Evaluation of insulin resistance in liver cirrhosis by means of the glucose clamp technique, Ital. J. Gastroenterol. 13: 255 (1981).Google Scholar
  49. 49.
    R. Taylor, R. Heine, J. Collins, K. G. M. Alberti, and O. F. W. James, No marked impairment of insulin binding to adipocytes in insulin resistant cirrhotics. VI International Congress of Liver Diseases. Basel, October 15–17, 1982. Abstract no. 193 (1982).Google Scholar
  50. 50.
    P. J. Randle, C. N. Hales, P. B. Garland, and E. A. Newsholme, The glucose fatty-acid cycle, its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus, Lancet 1: 7285 (1963).Google Scholar
  51. 51.
    E. A. Newsholme and C. Start, Regulation of fat metabolism in liver. Introduction. in:“Regulation in Metabolism;’ Chapter 7. John Wiley, London, New York, Toronto (1974).Google Scholar

Copyright information

© Plenum Press, New York 1984

Authors and Affiliations

  • P. B. Soeters
    • 1
  • J. E. G. de Boer
    • 1
  • R. J. Oostenbroek
    • 1
  • M. A. Janssen
    • 1
  1. 1.Departments of Surgery and Biochemistry, St. Annadal HospitalUniversity of LimburgMaastrichtThe Netherlands

Personalised recommendations